P1.12-21 Developing a Real-World 3L Comparator to CheckMate 032: Overall Survival (OS) in Patients With Small Cell Lung Cancer (SCLC)

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Third-Line Nivolumab Monotherapy in Recurrent Small Cell Lung Cancer: CheckMate 032

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P1.12-14 Survival of Patients With Small-Cell Lung Cancer Undergoing Surgical Resection

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Pcn60 - Real-World Overall Survival of Patients With Advanced Non-Small Cell Lung Cancer: Results of a Claims Data Study of Patients in Germany

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Temporal Trends From 1986 to 2008 in Overall Survival of Small Cell Lung Cancer Patients

Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2014English

Pcn1 - Real-World Effectiveness and Tolerability of Small-Cell Lung Cancer (Sclc) Treatments: A Systematic Literature Review (Slr)

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Can Long-Term Survival Be Improved in Patients With Small-Cell Lung Cancer (SCLC) and Good Performance Status?

British Journal of Cancer
Cancer ResearchOncology
1994English

Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2020English

P3.15-21 Real-World Experience of First-Line Afatinib Treatment in Patients With EGFR Mutant Advanced Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Nomograms Predict Overall Survival for Patients With Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy